Did you know? You can suggest edits to improve this peptide information.
Overview
What is Thymulin?
Thymulin (also known as Serum Thymic Factor or FTS - Facteur Thymique Sérique) is a 9-amino acid metallopeptide hormone produced exclusively by thymic epithelial cells. First characterized by Bach and colleagues in 1977, thymulin is unique in requiring zinc binding (1:1 equimolecular ratio) for biological activity. The zinc-thymulin complex adopts a specific three-dimensional conformation essential for its immunomodulatory functions, including T-cell differentiation, NK cell enhancement, and suppressor T-cell regulation. Beyond immune functions, thymulin demonstrates potent anti-inflammatory and analgesic properties through inhibition of NF-κB, p38 MAPK, and pro-inflammatory cytokines. Serum thymulin levels decline progressively with age (peaking in pre-adolescence), contributing to immunosenescence. Research shows promise in lung diseases, neuropathic pain, and age-related immune dysfunction, though human clinical trials remain limited.
Key Benefits
Immune modulation, T-cell differentiation, anti-inflammatory effects, potential analgesic properties
Mechanism of Action
Zinc-dependent metallopeptide that binds to high-affinity T-cell receptors. Induces T-cell differentiation, enhances suppressor T-cell function, and modulates NK cell activity. Anti-inflammatory action via NF-κB inhibition, p38 MAPK suppression, and reduction of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6). May also act through α7-nicotinic acetylcholine receptor potentiation for analgesic effects.
Molecular Information
Weight
858.86 Da (apo-thymulin); ~922 Da with zinc
Length
9 amino acids (nonapeptide)
Type
Metallopeptide hormone (zinc-dependent)
Amino Acid Sequence:
H-Pyr-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn-OH (pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn)
* N-terminal pyroglutamic acid (cyclized glutamine) provides aminopeptidase resistance. Requires 1:1 zinc binding for biological activity. Zinc coordination involves Ser4, Ser8, N-terminal pGlu, and potentially Gln5.
Pharmacokinetics
Research Indications
T-Cell Differentiation
Induces T-cell surface markers and functions in immature lymphoid cells, essential for adaptive immunity
Suppressor T-Cell Enhancement
Notably enhances suppressor T-cell function, helping regulate immune responses
NK Cell Activation
Enhances natural killer cell activity for improved innate immune surveillance
Research Protocols
Disclaimer
Thymulin is a research peptide with limited human data. It requires zinc for biological activity - the apo-peptide (without zinc) is biologically inactive. Ensure adequate zinc intake or supplementation. Dosing protocols derived from animal studies and anecdotal human use. Clinical research shows promise for immune modulation, anti-inflammatory effects, and pain management, but FDA-approved human trials are lacking. This is not medical advice. Consult a healthcare provider before use.
Timing
Very short half-life (~10 min). Natural thymulin follows circadian rhythm correlating with ACTH. Optimal timing unclear for exogenous administration.
Peptide Interactions
How to Reconstitute
Important
Zinc-dependent metallopeptide. Use BAC water or sterile water. CRITICAL: Thymulin requires zinc for biological activity - ensure adequate zinc intake or supplementation. Store lyophilized at -20°C, reconstituted at 2-8°C. Use within 7-10 days.
Store lyophilized powder at -20°C until use
Allow vial to reach room temperature
Add sterile water slowly down vial side
Gently swirl until dissolved -do not shake
Solution should be clear; discard if cloudy
Use reconstituted solution within 7-10 days
Store reconstituted at 2-8°C
Ensure adequate zinc intake for biological activity
Quality Indicators
Zinc dependency critical
Thymulin requires zinc for biological activity. Ensure adequate zinc status or supplementation.
Very short half-life
Serum half-life only ~10 minutes. Cellular/tissue effects may persist longer.
Limited human data
Most research is preclinical. Human dosing extrapolated from animal studies.
Excellent safety profile in studies
No toxicity observed even at high doses in animal models. No immunosuppressive effects.
Third-party testing recommended
Verify peptide identity and purity. Ensure zinc-bound form if available.
What to Expect
- Day 1-3: No immediate effects expected given mechanism
- Week 1-2: Potential immune parameter improvements (requires testing)
- For pain/inflammation: Effects may be noticeable within days in animal models
- Immune reconstitution may require multiple cycles over months
- Best results likely with adequate zinc status
Side Effects & Safety
- CRITICAL: Requires zinc for biological activity -supplement if needed
- Very short serum half-life (~10 minutes)
- No toxicity observed even at high doses in preclinical studies
- Did not affect normal physiological parameters in animal studies
- No immunosuppressive effects unlike corticosteroids
- Limited human safety data -preclinical research only
- Circadian variation in natural thymulin -timing may matter
- Not FDA approved for any indication
References
Potent Analgesic and Anti-inflammatory Actions of PAT in the Rat (2002)
Thymulin analog PAT (25-50 μg) abolished increased TNF-α and significantly reduced IL-1β, IL-6, and NGF levels. Demonstrated comparable or stronger analgesic effects than indomethacin and dexamethasone without affecting normal physiological parameters.
View Study (opens in new tab) →Thymulin Treatment Attenuates Inflammatory Pain via Spinal Mechanisms (2019)
Thymulin notably reduced thermal hyperalgesia and paw edema. Molecular analysis showed reduced microglial activation, p38 MAPK phosphorylation, and spinal pro-inflammatory cytokines (TNF-α, IL-6). Long-term treatment effective for neuroinflammation.
View Study (opens in new tab) →Immunomodulatory Role of Thymulin in Lung Diseases (2010)
Comprehensive review showing thymulin has consistent beneficial effects in experimental lung disease models. Broad inhibitory effect on pro-inflammatory cytokines, suppresses p38 (implicated in glucocorticoid resistance), and inhibits NF-κB. No toxicity even at high doses -good candidate for gene therapy.
View Study (opens in new tab) →Quick Start Guide
Community Poll
Question 1 of 10
What is your experience with this compound?
Poll Results
Loading results...
Community Insights
Self-reported by PepPedia users. Not clinical evidence. Health changes reflect all users, including those taking multiple compounds.
Was this helpful?
Your feedback helps us improve PepPedia